Daniel Robert Hostetter
20Patents
7h-index
18Co-inventors
58Inventor score
Filing activity: Sep 25, 2013 → Jun 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10138272B2 | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof | Chemistry; Metallurgy | 24 | Active |
| US9562073B2 | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof | Chemistry; Metallurgy | 23 | Active |
| US10669337B2 | Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same | Chemistry; Metallurgy | 18 | Active |
| US10336824B2 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof | Chemistry; Metallurgy | 12 | Active |
| US9487590B2 | Activatable antibodies that bind interleukin-6 receptor and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10669339B2 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US11161906B2 | Multispecific antibodies, multispecific activatable antibodies and methods of using the same | Chemistry; Metallurgy | 7 | Active |
| US11028126B2 | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11046759B2 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US9255155B2 | Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer | Chemistry; Metallurgy | 1 | Active |
| US9695249B2 | Antibodies specific for urokinase-type plasminogen activator and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11548943B2 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10239954B2 | Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11884746B2 | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11174316B2 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11814410B2 | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11802158B2 | Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US11472875B1 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11548944B2 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10611845B2 | Activatable antibodies that bind interleukin-6 receptor and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.